VR Logo

Glenmark Pharmaceuticals Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

49 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech
Director's
Report
Management
Discussion
Corporate
Governance
Auditor's
Report
Notes to
Accounts
2021 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2020 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2019 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2018 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2017 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2016 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2015 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2014 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2013 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2012 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2011 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2010 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2009 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2008 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2007 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2006 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2005 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2004 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2003 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2002 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2001 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2000 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1977

Chairman: Glenn Saldanha

Managing Director: Glenn Saldanha

Group: Glenmark

Listing: NSE: GLENMARK, BSE: 532296

Headquarters: Mumbai, Maharashtra

Website: www.glenmarkpharma.com

Key Facts

Market cap: R 14,178.95 Cr

Revenue (TTM): R 11,759.00 Cr

Earnings (TTM): R 1,063.38 Cr

Cash: R 1,139.16 Cr

Total Debt: R 4,687.43 Cr

Promoters' ownership: 46.65%

Liquidity: High

52 Week range: R 442.05 - 690.95

Face value: R1.00

Shares outstanding: 28,21,68,156

10 Years Aggregate:

  • CFO: 9,285.85 Cr
  • EBITDA: 14,492.22 Cr
  • Net Profit: 7,174.39 Cr

Stock Performance

Time Period Glenmark Pharma. S&P BSE Healthcare S&P BSE Mid Cap
YTD2.4216.9340.38
1 month-2.020.42-2.61
3 months-6.12-5.123.66
1 Year5.3722.8546.71
3 Years-8.1720.8718.70
5 Years-10.1210.1615.59
10 Years4.7415.2515.88
As on 02-Dec-2021
Year Glenmark Pharma. S&P BSE Mid Cap S&P BSE Healthcare
202042.7519.8761.45
2019-49.80-3.05-3.55
201816.43-13.31-5.89
2017-33.0648.130.49
2016-3.827.97-12.88
201518.887.4315.06
201445.2754.6947.43